by GAtherton | Mar 7, 2019 | Information and Learning, Latest research news
The yeast Candida albicans lives in the gut as a commensal organism, usually without issue. C. albicans causes the body to produce a particular kind of immune cell, called Th17 sensitive cells, that stop the Candida from causing infections. A new research paper out...
by GAtherton | Feb 28, 2019 | Information and Learning, Latest research news, Lifestyle and Coping Skills
In last month’s patient meetings here at Wythenshawe Hospital, the topic of pulmonary rehabilitation (PR) came up. Some people said it had been useful, some people felt pushed into it, some people felt it was too much and actually made them feel worse instead of...
by GAtherton | Feb 7, 2019 | Latest research news
It is extremely important that we are able to diagnose someone with aspergillosis as quickly as possible, as the earlier treatment is begun, the better the outcome. People who have chronic forms of aspergillosis – such as Chronic Pulmonary Aspergillosis (CPA),...
by GAtherton | Jan 25, 2019 | Latest research news
Allergic Fungal Sinusitis (AFS) is a common type of fungal infection which affects the sinuses. The infection is caused by fungi found in the environment and leads to an allergic reaction in patients, resulting in very thick mucus, fungal debris collecting in the...
by GAtherton | Jan 25, 2019 | Latest research news
A study in Brazil, which looked at levels of anti-fungal drug resistance in 228 Aspergillus isolates from patients has found that 27% of Aspergillus fumigatus isolates showed resistance to Amphotericin B. Aspergillosis is the most common acute...
by GAtherton | Dec 13, 2018 | Latest research news
Itraconazole is widely used as an adjunctive treatment to help manage allergic forms of aspergillosis (eg. Allergic Bronchopulmonary Aspergillosis), as it can minimise the dose of oral steroids required to control respiratory symptoms. This is...